Analysis of mutations in primary and metastatic synovial sarcoma

Synovial sarcoma is the most common pediatric non-rhabdomyosarcoma soft tissue sarcoma and accounts for about 8–10% of all soft tissue sarcoma in childhood and adolescence. The presence of a chromosomal translocation-associated SS18-SSX-fusion gene is causally linked to development of primary synovial sarcoma. Metastases occur in approximately 50–70% of synovial sarcoma cases with yet unknown mechanisms, which led to about 70–80% mortality rate in five years. To explore the possibilities to investigate metastatic mechanisms of synovial sarcoma, we carried out the first genome-wide search for potential genetic biomarkers and drivers associated with metastasis by comparative mutational profiling of 18 synovial sarcoma samples isolated from four patients carrying the primary tumors and another four patients carrying the metastatic tumors through whole exome sequencing. Selected from the candidates yielded from this effort, we examined the effect of the multiple missense mutations of ADAM17, which were identified solely in metastatic synovial sarcoma. The mutant alleles as well as the wild-type control were expressed in the mammalian cells harboring the SS18-SSX1 fusion gene. The ADAM17-P729H mutation was shown to enhance cell migration, a phenotype associated with metastasis. Therefore, like ADAM17-P729H, other mutations we identified solely in metastatic synovial sarcoma may also have the potential to serve as an entry point for unraveling the metastatic mechanisms of synovial sarcoma.

[1]  S. Linnarsson,et al.  Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs) , 2018, BMC Cancer.

[2]  R. C. Poulos,et al.  The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. , 2017, Cancer research.

[3]  Soo Hyun Lee,et al.  ARID1B alterations identify aggressive tumors in neuroblastoma , 2017, Oncotarget.

[4]  T. Olencki,et al.  Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors , 2017, Cancer.

[5]  H. Groen,et al.  Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors , 2016, Carcinogenesis.

[6]  K. Jang,et al.  CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients. , 2016, The American journal of pathology.

[7]  Lifeng Gong,et al.  Nox1 promotes colon cancer cell metastasis via activation of the ADAM17 pathway. , 2016, European review for medical and pharmacological sciences.

[8]  Li Ding,et al.  The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis , 2016, Oncogene.

[9]  D. Largaespada,et al.  Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. , 2016, Cell reports.

[10]  D. Orbach,et al.  [Synovial sarcoma in children and adolescents]. , 2016, Bulletin du cancer.

[11]  L. Pang,et al.  Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip , 2015, BMC Medical Genomics.

[12]  C. Morrison,et al.  Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib , 2015, Cold Spring Harbor molecular case studies.

[13]  Rolph Pfundt,et al.  Next generation sequencing in synovial sarcoma reveals novel gene mutations , 2015, Oncotarget.

[14]  H. Jahr,et al.  A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation , 2015, Cellular and Molecular Life Sciences.

[15]  Hui Li,et al.  A1 adenosine receptor–stimulated exocytosis in bladder umbrella cells requires phosphorylation of ADAM17 Ser-811 and EGF receptor transactivation , 2014, Molecular biology of the cell.

[16]  S. Ferrari,et al.  Emerging therapeutic targets for synovial sarcoma , 2014, Expert review of anticancer therapy.

[17]  P. Dileo,et al.  What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients , 2014, British Journal of Cancer.

[18]  S. Lee,et al.  Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers , 2014, PloS one.

[19]  Yujian Shi,et al.  Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas , 2014, BMC Medical Genomics.

[20]  S Gowrishankar,et al.  ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines , 2013, British Journal of Cancer.

[21]  P. Buckhaults,et al.  Somatic Mutations, Allele Loss, and DNA Methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) Gene Reveals Association with Early Age of Diagnosis in Colorectal Cancer Patients , 2013, PloS one.

[22]  Giovanni Parmigiani,et al.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.

[23]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[24]  A. Shinagare,et al.  Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. , 2012, AJR. American journal of roentgenology.

[25]  Jong-Wan Park,et al.  Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation* , 2011, The Journal of Biological Chemistry.

[26]  L. Guillou,et al.  Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years , 2011, Journal of children's orthopaedics.

[27]  Kenneth H. Buetow,et al.  Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .

[28]  K. Siebenrock,et al.  Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  P. Higgins,et al.  In Vivo Selection of a Missense Mutation in adeR and Conversion of the Novel blaOXA-164 Gene into blaOXA-58 in Carbapenem-Resistant Acinetobacter baumannii Isolates from a Hospitalized Patient , 2010, Antimicrobial Agents and Chemotherapy.

[30]  M. Stevens,et al.  Synovial sarcoma in childhood and adolescence: A retrospective series of 77 patients registered by the Children's Cancer and Leukaemia Group between 1991 and 2006 , 2010, Pediatric blood & cancer.

[31]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[32]  M. Gooz.  ADAM-17: the enzyme that does it all , 2010, Critical reviews in biochemistry and molecular biology.

[33]  R. Derynck,et al.  Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. , 2010, Molecular cell.

[34]  B. Su,et al.  SSeCKS/Gravin/AKAP12 Inhibits Cancer Cell Invasiveness and Chemotaxis by Suppressing a Protein Kinase C- Raf/MEK/ERK Pathway* , 2009, The Journal of Biological Chemistry.

[35]  Samy Lamouille,et al.  TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. , 2009, Molecular cell.

[36]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[37]  Tara L. Naylor,et al.  Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues , 2009, Cancer biology & therapy.

[38]  H. Paudel,et al.  Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro* , 2009, Journal of Biological Chemistry.

[39]  D. Edwards,et al.  The ADAM metalloproteinases , 2008, Molecular Aspects of Medicine.

[40]  J. Arribas,et al.  Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17 , 2008, Biological chemistry.

[41]  M. Capecchi,et al.  Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling , 2008, Clinical orthopaedics and related research.

[42]  Randal L. Croshaw,et al.  Somatic mutations to CSMD1 in colorectal adenocarcinomas , 2008, Cancer biology & therapy.

[43]  P. Lander,et al.  Synovial sarcoma: clinicopathologic features, treatment, and prognosis. , 2007, Orthopedics.

[44]  M. Menger,et al.  Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. , 2007, Neoplasia.

[45]  Y. Okada,et al.  ADAMs in cancer cell proliferation and progression , 2007, Cancer science.

[46]  Malay Haldar,et al.  A conditional mouse model of synovial sarcoma: insights into a myogenic origin. , 2007, Cancer cell.

[47]  S. Soond,et al.  ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking , 2005, Journal of Cell Science.

[48]  C. Blobel,et al.  ADAMs: key components in EGFR signalling and development , 2005, Nature Reviews Molecular Cell Biology.

[49]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[50]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[51]  Kenji Shimizu,et al.  Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. , 2004, Cancer letters.

[52]  R. Derynck,et al.  Characterization of Growth Factor-induced Serine Phosphorylation of Tumor Necrosis Factor-α Converting Enzyme and of an Alternatively Translated Polypeptide* , 2003, The Journal of Biological Chemistry.

[53]  M. Munsell,et al.  Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  R. Mariani-Costantini,et al.  A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. , 2003, The Journal of clinical endocrinology and metabolism.

[55]  D. Seals,et al.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions. , 2003, Genes & development.

[56]  E. Dı́az-Rodrı́guez,et al.  Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. , 2002, Molecular biology of the cell.

[57]  H. Sonobe,et al.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Blobel,et al.  Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. , 1999, The Biochemical journal.

[59]  J. Lopes,et al.  Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. , 1997, Human molecular genetics.

[60]  H. Ohguro.  High levels of rhodopsin phosphorylation in missense mutations of C‐terminal region of rhodopsin , 1997, FEBS letters.

[61]  B. Castner,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.